CHANTELLE K GASTINGER PA-C
Prescription History 1619925708
Physician Assistant in Exton, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for CHANTELLE K GASTINGER PA-C, an active Physician Assistant specialist practicing in Exton, PA. Our medical registry currently tracks 9 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 288 documented patient claims. Among these therapy options, the most frequently utilized medication is Fluorouracil, which accounts for 73 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| Fluorouracil | 73 | $83.64 | ▲ More than typical |
About Fluorouracil: This medication is used on the skin to treat pre-cancerous and cancerous skin growths. Show more ▾ Fluorouracil belongs to a class of medications known as anti-metabolites. It works by blocking the growth of abnormal cells that cause the skin condition. A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. In 2024, this provider wrote 73 Medicare prescriptions for Fluorouracil, about 1.9 times the volume of the typical Pennsylvania prescriber of this medication (38.4). Medicare paid an average of $83.64 per fill, versus $64.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 75.4 30-Day Fills standardized to 30-day supplies 1,943 Days of Medication total across all patients in 2024 | |||
| Clobetasol Propionate | 56 | $87.63 | ▲ More than typical |
About Clobetasol Propionate: This medication is used to treat a variety of skin conditions (such as eczema, psoriasis, dermatitis, allergies, rash). Show more ▾ Clobetasol reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid. A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression. In 2024, this provider wrote 56 Medicare prescriptions for Clobetasol Propionate, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (39). Medicare paid an average of $87.63 per fill, versus $45.83 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 56.3 30-Day Fills standardized to 30-day supplies 1,285 Days of Medication total across all patients in 2024 | |||
| Fluocinonide | 33 | $47.75 | ≈ Typical |
About Fluocinonide: This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, psoriasis, allergies, rash). Show more ▾ Fluocinonide reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a strong corticosteroid. A topical glucocorticoid used in the treatment of ECZEMA. In 2024, this provider wrote 33 Medicare prescriptions for Fluocinonide, about the same volume as the typical Pennsylvania prescriber of this medication (33.2). Medicare paid an average of $47.75 per fill, versus $40.24 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 710 Days of Medication total across all patients in 2024 | |||
| Imiquimod | 26 | $30.47 | ≈ Typical |
About Imiquimod: This medication is used to treat certain types of growths on the skin. Show more ▾ These are precancerous growths (actinic keratoses), a certain type of skin cancer (superficial basal cell carcinoma), and warts on the outside of the genitals/anus. Treating these conditions can decrease complications from them. Imiquimod belongs to a group of drugs called immune response modifiers. It is believed to work by helping to activate your immune system to fight these abnormal skin growths. This product is not recommended for use on children under 12 years of age unless specifically directed by your doctor. A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial BASAL CELL CARCINOMA; and ACTINIC KERATOSIS. In 2024, this provider wrote 26 Medicare prescriptions for Imiquimod, about 80% of the volume of the typical Pennsylvania prescriber of this medication (32.6). Medicare paid an average of $30.47 per fill, versus $29.97 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26 30-Day Fills standardized to 30-day supplies 620 Days of Medication total across all patients in 2024 | |||
| Triamcinolone Acetonide | 26 | $12.08 | ▼ Less than typical |
About Triamcinolone Acetonide: This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, allergies, rash). Show more ▾ Triamcinolone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium- to strong-potency corticosteroid. The potency depends on the strength and the form that you use. For details on the potency of your product, ask your pharmacist. An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions. In 2024, this provider wrote 26 Medicare prescriptions for Triamcinolone Acetonide, about 69% of the volume of the typical Pennsylvania prescriber of this medication (37.5). Medicare paid an average of $12.08 per fill, versus $9.88 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27 30-Day Fills standardized to 30-day supplies 667 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 24 | $47.50 | ≈ Typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 24 Medicare prescriptions for Doxycycline Hyclate, about 75% of the volume of the typical Pennsylvania prescriber of this medication (31.9). Medicare paid an average of $47.50 per fill, versus $12.34 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,028 Days of Medication total across all patients in 2024 | |||
| OtezlaApremilast | 20 | $4,656.15▼ below PA avg | ≈ Typical |
About Otezla: This medication is used to treat a certain type of arthritis (psoriatic arthritis). Show more ▾ Apremilast is also used to treat a certain type of skin condition (moderate to severe plaque psoriasis). Apremilast belongs to a class of drugs known as phosphodiesterase 4 (PDE4) inhibitors. For the treatment of psoriatic arthritis, it decreases pain and swelling, and may help improve flexibility in the affected joints. For the treatment of plaque psoriasis, it may help to reduce the redness, thickening, and scaling of the skin that occurs with this condition. Apremilast is also used to treat mouth sores in people who have Behcet's disease. It helps to reduce the pain and improve the healing of these mouth sores. A PDE4 inhibitor with anti-ulcer activity. In 2024, this provider wrote 20 Medicare prescriptions for Otezla, about the same volume as the typical Pennsylvania prescriber of this medication (21.9). Medicare paid an average of $4,656.15 per fill, versus $4,726.72 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Ketoconazole | 17 | $26.91 | ▼ Less than typical |
About Ketoconazole: Ketoconazole is used to treat skin infections such as athlete's foot, jock itch, ringworm, and certain kinds of dandruff. Show more ▾ This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Ketoconazole is an azole antifungal that works by preventing the growth of fungus. Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. In 2024, this provider wrote 17 Medicare prescriptions for Ketoconazole, about a third of the volume of the typical Pennsylvania prescriber of this medication (46.9). Medicare paid an average of $26.91 per fill, versus $20.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 544 Days of Medication total across all patients in 2024 | |||
| Dupixent SyringeDupilumab | 13 | $3,843.15▼ below PA avg | ▼ Less than typical |
About Dupixent Syringe: This medication is used to treat certain skin conditions (eczema, prurigo nodularis) and a certain esophagus problem (eosinophilic esophagitis). Show more ▾ It is also used along with other medications to help control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD). In addition, dupilumab may be used to reduce symptoms caused by nasal polyps and the long-term swelling of the sinuses and nasal passage (chronic rhinosinusitis with nasal polyposis). Dupilumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking certain natural proteins in your body (interleukin-4 and interleukin-13) that may cause inflammation and swelling. This medication should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Targets the alpha subunit of interleukin-4 receptor. In 2024, this provider wrote 13 Medicare prescriptions for Dupixent Syringe, about half the volume of the typical Pennsylvania prescriber of this medication (21.9). Medicare paid an average of $3,843.15 per fill, versus $3,917.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for CHANTELLE K GASTINGER PA-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Physician Assistant prescribing approach at this Exton, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among PA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
